Melba Hernandez

Statistics

Publications

Citations

360

H-Index

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Melba Hernandez is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, lipid-lowering therapy, and lipid metabolism.

Publications per year

2002–2013

Publications

Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice

Hélène Duez, Yu‐Sheng Chao, Melba Hernandez et al. · Journal of Biological Chemistry · 2002 · 188 citations · Full text

Medicine, Cardiology, Pharmacology +16

Novel 2,3-Dihydrobenzofuran-2-carboxylic Acids: Highly Potent and Subtype-Selective PPARα Agonists with Potent Hypolipidemic Activity

Guo Q. Shi, James F. Dropinski, Yong Zhang et al. · Journal of Medicinal Chemistry · 2005 · 101 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

A Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist Demonstrates Favorable Effects on Lipid Homeostasis

Qiu Guo, Soumya P. Sahoo, Pei-Ran Wang et al. · Endocrinology · 2004 · 40 citations · Full text

Life Sciences, Endocrinology, Pharmacology +16

Heterozygous Disruption of Renal Outer Medullary Potassium Channel in Rats Is Associated With Reduced Blood Pressure

Xiaoyan Zhou, Zuo Zhang, Myung K. Shin et al. · Hypertension · 2013 · 31 citations · Full text

Medicine, Molecular Genetics, Physiology +17

1–4 of 4